List of Tables
Table 1. Global In-Vitro Cancer Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Instruments
Table 3. Key Players of Reagents and Kits
Table 4. Global In-Vitro Cancer Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global In-Vitro Cancer Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global In-Vitro Cancer Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global In-Vitro Cancer Diagnostics Market Share by Region (2019-2024)
Table 8. Global In-Vitro Cancer Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global In-Vitro Cancer Diagnostics Market Share by Region (2025-2030)
Table 10. In-Vitro Cancer Diagnostics Market Trends
Table 11. In-Vitro Cancer Diagnostics Market Drivers
Table 12. In-Vitro Cancer Diagnostics Market Challenges
Table 13. In-Vitro Cancer Diagnostics Market Restraints
Table 14. Global In-Vitro Cancer Diagnostics Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global In-Vitro Cancer Diagnostics Market Share by Players (2019-2024)
Table 16. Global Top In-Vitro Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Cancer Diagnostics as of 2023)
Table 17. Ranking of Global Top In-Vitro Cancer Diagnostics Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by In-Vitro Cancer Diagnostics Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players In-Vitro Cancer Diagnostics Product Solution and Service
Table 21. Date of Enter into In-Vitro Cancer Diagnostics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global In-Vitro Cancer Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global In-Vitro Cancer Diagnostics Revenue Market Share by Type (2019-2024)
Table 25. Global In-Vitro Cancer Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global In-Vitro Cancer Diagnostics Revenue Market Share by Type (2025-2030)
Table 27. Global In-Vitro Cancer Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global In-Vitro Cancer Diagnostics Revenue Market Share by Application (2019-2024)
Table 29. Global In-Vitro Cancer Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global In-Vitro Cancer Diagnostics Revenue Market Share by Application (2025-2030)
Table 31. North America In-Vitro Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America In-Vitro Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America In-Vitro Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe In-Vitro Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe In-Vitro Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe In-Vitro Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific In-Vitro Cancer Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America In-Vitro Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America In-Vitro Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America In-Vitro Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa In-Vitro Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 46. MDx Health Quest Diagnostics Company Detail
Table 47. MDx Health Quest Diagnostics Business Overview
Table 48. MDx Health Quest Diagnostics In-Vitro Cancer Diagnostics Product
Table 49. MDx Health Quest Diagnostics Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 50. MDx Health Quest Diagnostics Recent Development
Table 51. R-Biopharm AG Company Detail
Table 52. R-Biopharm AG Business Overview
Table 53. R-Biopharm AG In-Vitro Cancer Diagnostics Product
Table 54. R-Biopharm AG Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 55. R-Biopharm AG Recent Development
Table 56. Signature Diagnostics Company Detail
Table 57. Signature Diagnostics Business Overview
Table 58. Signature Diagnostics In-Vitro Cancer Diagnostics Product
Table 59. Signature Diagnostics Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 60. Signature Diagnostics Recent Development
Table 61. Siemens Healthcare Company Detail
Table 62. Siemens Healthcare Business Overview
Table 63. Siemens Healthcare In-Vitro Cancer Diagnostics Product
Table 64. Siemens Healthcare Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 65. Siemens Healthcare Recent Development
Table 66. Randox Laboratories Company Detail
Table 67. Randox Laboratories Business Overview
Table 68. Randox Laboratories In-Vitro Cancer Diagnostics Product
Table 69. Randox Laboratories Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 70. Randox Laboratories Recent Development
Table 71. Epigenomics AG Company Detail
Table 72. Epigenomics AG Business Overview
Table 73. Epigenomics AG In-Vitro Cancer Diagnostics Product
Table 74. Epigenomics AG Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 75. Epigenomics AG Recent Development
Table 76. Beckman Coulter Company Detail
Table 77. Beckman Coulter Business Overview
Table 78. Beckman Coulter In-Vitro Cancer Diagnostics Product
Table 79. Beckman Coulter Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 80. Beckman Coulter Recent Development
Table 81. Abbott Laboratories Company Detail
Table 82. Abbott Laboratories Business Overview
Table 83. Abbott Laboratories In-Vitro Cancer Diagnostics Product
Table 84. Abbott Laboratories Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 85. Abbott Laboratories Recent Development
Table 86. Burning Rock Company Detail
Table 87. Burning Rock Business Overview
Table 88. Burning Rock In-Vitro Cancer Diagnostics Product
Table 89. Burning Rock Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 90. Burning Rock Recent Development
Table 91. Novogene Company Detail
Table 92. Novogene Business Overview
Table 93. Novogene In-Vitro Cancer Diagnostics Product
Table 94. Novogene Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 95. Novogene Recent Development
Table 96. Geneseeq Company Detail
Table 97. Geneseeq Business Overview
Table 98. Geneseeq In-Vitro Cancer Diagnostics Product
Table 99. Geneseeq Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 100. Geneseeq Recent Development
Table 101. Amoy Diagnostics Co.,Ltd. Company Detail
Table 102. Amoy Diagnostics Co.,Ltd. Business Overview
Table 103. Amoy Diagnostics Co.,Ltd. In-Vitro Cancer Diagnostics Product
Table 104. Amoy Diagnostics Co.,Ltd. Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 105. Amoy Diagnostics Co.,Ltd. Recent Development
Table 106. Daan Gene Company Detail
Table 107. Daan Gene Business Overview
Table 108. Daan Gene In-Vitro Cancer Diagnostics Product
Table 109. Daan Gene Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 110. Daan Gene Recent Development
Table 111. Fosun Pharma Company Detail
Table 112. Fosun Pharma Business Overview
Table 113. Fosun Pharma In-Vitro Cancer Diagnostics Product
Table 114. Fosun Pharma Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 115. Fosun Pharma Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global In-Vitro Cancer Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global In-Vitro Cancer Diagnostics Market Share by Type: 2023 VS 2030
Figure 3. Instruments Features
Figure 4. Reagents and Kits Features
Figure 5. Global In-Vitro Cancer Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global In-Vitro Cancer Diagnostics Market Share by Application: 2023 VS 2030
Figure 7. Laboratories Case Studies
Figure 8. Hospitals Case Studies
Figure 9. Others Case Studies
Figure 10. In-Vitro Cancer Diagnostics Report Years Considered
Figure 11. Global In-Vitro Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global In-Vitro Cancer Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global In-Vitro Cancer Diagnostics Market Share by Region: 2023 VS 2030
Figure 14. Global In-Vitro Cancer Diagnostics Market Share by Players in 2023
Figure 15. Global Top In-Vitro Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Cancer Diagnostics as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by In-Vitro Cancer Diagnostics Revenue in 2023
Figure 17. North America In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America In-Vitro Cancer Diagnostics Market Share by Country (2019-2030)
Figure 19. United States In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe In-Vitro Cancer Diagnostics Market Share by Country (2019-2030)
Figure 23. Germany In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific In-Vitro Cancer Diagnostics Market Share by Region (2019-2030)
Figure 31. China In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America In-Vitro Cancer Diagnostics Market Share by Country (2019-2030)
Figure 39. Mexico In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa In-Vitro Cancer Diagnostics Market Share by Country (2019-2030)
Figure 43. Turkey In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. MDx Health Quest Diagnostics Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)
Figure 46. R-Biopharm AG Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)
Figure 47. Signature Diagnostics Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)
Figure 48. Siemens Healthcare Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)
Figure 49. Randox Laboratories Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)
Figure 50. Epigenomics AG Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)
Figure 51. Beckman Coulter Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)
Figure 52. Abbott Laboratories Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)
Figure 53. Burning Rock Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)
Figure 54. Novogene Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)
Figure 55. Geneseeq Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)
Figure 56. Amoy Diagnostics Co.,Ltd. Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)
Figure 57. Daan Gene Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)
Figure 58. Fosun Pharma Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed